[Hengrui Medicine: Net profit in the third quarter increased by 89% year-on-year and 12% month-on-month] On October 27, Hengrui Medicine (600276.SH) announced that its operating income in the third quarter was 8.953 billion yuan, a year-on-year increase of 20.55%; the net profit attributable to shareholders of listed companies was 2.458 billion yuan, a year-on-year increase of 88.92%. In the first three quarters, operating income was 24.409 billion yuan, a year-on-year increase of 5.26%; net profit attributable to shareholders of listed companies was 6.923 billion yuan, a year-on-year increase of 20.38%. The change in performance was mainly due to the increase in external licensing income during the reporting period. Xiaocai Note: The company’s Q3 net profit was 2.458 billion and Q2 net profit was 2.183 billion. Based on this calculation, Q3 net profit increased by 12% month-on-month.